Standing brief
Temple Protocol is a research-grade editorial practice in the field of longevity medicine. We synthesize current literature on supplements, peptides, and aging interventions for adults who are actively engaged with their health practice — typically between the ages of 50 and 75.
We are not a supplement brand, a clinic, or an influencer operation. We are editorial: every claim traces to a source, every confidence label is honest, every piece of content is conditional. The methodology is published at templeprotocol.ai/evidence.
The first product — the Bio Stack Audit — is an AI-assisted interaction and confidence review for supplement and peptide stacks. It is in development, pending legal and clinical review. It is not a medical device and does not provide medical advice.
Temple Protocol is a brand of Echelon Seven LLC, based in Nashville, Tennessee. Founder: Aaron De Young.